AHA files amicus brief in 4th Circuit in support of Maryland 340B contract pharmacy law
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to affirm a decision by the U.S. District Court for the District of Maryland in September to deny a preliminary injunction sought by drug companies and PhRMA against enforcement of Maryland's state law protecting 340B pricing for contract pharmacy arrangements.
The AHA also filed amicus briefs in the district court in July and August, defending Maryland’s law against drug industry efforts to enjoin it.
Others joining AHA in the Feb. 28 filing were 340B Health, the Maryland Hospital Association, the Mid-Atlantic Association of Community Health Centers and the American Society of Health-System Pharmacists.
Related News Articles
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
The 4th U.S. Circuit Court of AppealsMay 28 agreed to rehear challenges to 340B contract pharmacy laws from West Virginia and Maryland. In April, a three-judge…
Headline
The Wall Street Journal today published a letter to the editor from AHA General Counsel Chad Golder responding to a May 7 editorial criticizing the 340B Drug…
Headline
The White House May 18 announced an expansion of TrumpRx.gov, which now features more than 600 generic drugs. The direct-to-consumer platform serves as a hub…
Headline
The AHA today urged Eli Lilly to abandon its 340B Drug Pricing Program claims-data policy and work with the AHA to develop a functional third-party…
Headline
The Department of Health and Human Services yesterday announced an action plan on psychiatric prescribing, including efforts to initiate …